Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Autoimmun. 2010 May;34(3):J322-6. doi: 10.1016/j.jaut.2009.11.008.

Hepatitis C and interferon induced thyroiditis.

Author information

  • 1Department of Medicine, Division of Endocrinology, Box 1118, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA. Yaron.Tomer@mssm.edu

Abstract

Autoimmune thyroid diseases (AITDs) are complex diseases that develop as a result of interactions between genetic, epigenetic, and environmental factors. Significant progress has been made in our understanding of the genetic and environmental triggers contributing to AITD. The major environmental triggers of AITD include iodine, smoking, medications, pregnancy, and possibly stress. In this review we will focus on two well-documented environmental triggers of AITD, hepatitis C virus (HCV) infection and interferon alpha (IFNa) therapy. Chronic HCV infection has been shown to be associated with increased incidence of clinical and subclinical autoimmune thyroiditis (i.e. the presence of thyroid antibodies in euthyroid subjects). Moreover, IFNa therapy of chronic HCV infection is associated with subclinical or clinical thyroiditis in up to 40% of cases which can be autoimmune, or non-autoimmune thyroiditis. In some cases interferon induced thyroiditis (IIT) in chronic HCV patients may result in severe symptomatology necessitating discontinuation of therapy. While the epidemiology and clinical presentation of HCV and interferon induced thyroiditis have been well characterized, the mechanisms causing these conditions are still poorly understood.

Copyright 2009 Elsevier Ltd. All rights reserved.

PMID:
20022216
[PubMed - indexed for MEDLINE]
PMCID:
PMC2835812
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk